Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04870112
Title A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer (SCope-D1)
Acronym SCope-D1
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Age Groups: adult | senior
Covered Countries USA | NZL | ESP

No variant requirements are available.